Cartesian Therapeutics grants new hires stock options for 59,700 shares at USD 9.27 each

PUBT · 1d ago
Cartesian Therapeutics grants new hires stock options for 59,700 shares at USD 9.27 each
  • Cartesian Therapeutics granted stock options covering 59,700 shares to three new employees under its 2018 employment inducement plan.
  • Exercise price set at USD 9.27 per share, matching the Nasdaq closing price on Sept. 4, 2026.
  • Vesting starts with 25% on Sept. 4, 2027, then monthly installments, reaching full vesting on Sept. 4, 2030.
  • Options carry a 10-year term.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cartesian Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609080700PRIMZONEFULLFEED9821900) on September 08, 2026, and is solely responsible for the information contained therein.